Winner Medical Co., Ltd. (300888.SZ)
CNY 40.96
(0.1%)
CNY 40.96
(0.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.29 Billion | 2.98 Billion | 871.68 Million | 4.76 Billion | 599.77 Million | 467.86 Million |
| Net Income | 580.4 Million | 1.67 Billion | 1.23 Billion | 3.82 Billion | 547.19 Million | 425.47 Million |
| Depreciation & Amortization | 595.02 Million | 481.73 Million | 376.71 Million | 158.62 Million | 103.42 Million | 94.45 Million |
| Deferred income taxes | 27.81 Million | -72.52 Million | 21.37 Million | -61.4 Million | -18.09 Million | - |
| Stock-based compensation | 3.15 Million | - | - | - | - | - |
| Change in working capital | -413.93 Million | 422.73 Million | -768.92 Million | 345.71 Million | -115.39 Million | -131.58 Million |
| Other non-cash items | 2.14 Billion | 480.69 Million | 26.45 Million | 440.6 Million | 64.54 Million | 79.5 Million |
| Investing Cash Flow | 795.91 Million | -3.81 Billion | 478.8 Million | -4.42 Billion | -419.66 Million | -637.21 Million |
| Investments in PPE | -753.06 Million | -1.19 Billion | -743.26 Million | -573.26 Million | -446.9 Million | -638.14 Million |
| Acquisitions | -39.03 Million | -1.67 Billion | 190.93 Million | 819.57 Million | 34.36 Million | 1.07 Million |
| Investment purchases | -4.65 Billion | -9.18 Billion | -6.24 Billion | -8.42 Billion | -1.17 Billion | -326.54 Million |
| Sales/Maturities of investments | 6.24 Billion | 8.17 Billion | 7.27 Billion | 4.32 Billion | 1.17 Billion | 327.19 Million |
| Other Investing Activities | 1.93 Billion | 63.2 Million | 0.36 | -573.26 Million | -8.54 Million | -798.03 Thousand |
| Financing Cash Flow | -1.78 Billion | 1.11 Billion | -1.4 Billion | 3.34 Billion | -98.39 Million | 143.31 Million |
| Debt repayment | -683.1 Million | -149.94 Million | -150 Million | -109.21 Million | -474.58 Million | -663.98 Million |
| Dividends payments | -797.5 Million | -377.76 Million | -767.68 Million | -98.5 Million | -43 Million | -58.35 Million |
| Common Stock Repurchased | - | -242.09 Million | -257.99 Million | - | - | - |
| Common Stock Issuance | - | 242.09 Million | 257.99 Million | -33.72 Million | - | - |
| Other Financing Activities | -24.12 Million | 1.66 Billion | -491.44 Million | 3.45 Billion | 431.69 Million | 865.65 Million |
| Accounts receivables | 182.4 Million | 42.54 Million | -27.09 Million | -499.62 Million | -54.23 Million | -171.21 Million |
| Accounts payables | -578.41 Million | 526.24 Million | -289.56 Million | 1.27 Billion | 127.3 Million | - |
| Inventory | -53.1 Million | -73.52 Million | -473.63 Million | -365.64 Million | -170.37 Million | -94.5 Million |
| Other working capital | 35.17 Million | -72.52 Million | 21.37 Million | -61.4 Million | -18.09 Million | -37.07 Million |
| Cash at beginning of period | 4.52 Billion | 4.08 Billion | 4.14 Billion | 459.16 Million | 375.51 Million | 399.66 Million |
| Cash at end of period | 4.7 Billion | 4.37 Billion | 4.08 Billion | 4.14 Billion | 459.16 Million | 375.51 Million |
| Capital Expenditure | -753.06 Million | -1.19 Billion | -743.26 Million | -573.26 Million | -446.9 Million | -638.14 Million |
| Effect of forex changes on cash | -1.65 Million | -654.52 Thousand | -1.98 Million | 4.92 Million | 1.94 Million | 1.88 Million |
| Net cash flow / Change in cash | 179.25 Million | 282.2 Million | -61.12 Million | 3.69 Billion | 83.65 Million | -24.15 Million |
| Free Cash Flow | 544.62 Million | 1.78 Billion | 128.42 Million | 4.19 Billion | 152.87 Million | -170.28 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 168.81 Million | 201.72 Million | 182.42 Million | -1.56 Billion | 580.4 Million | 1.46 Billion |
| Depreciation & Amortization | - | 150.26 Million | 150.26 Million | 158.58 Million | 595.02 Million | -249.48 Million |
| Deferred income taxes | - | - | - | - | 27.81 Million | 546.77 Million |
| Stock-based compensation | - | 2.9 Million | - | 3.15 Million | 3.15 Million | -969.37 Thousand |
| Change in working capital | - | -201.95 Million | - | 164.47 Million | -413.93 Million | -367.12 Million |
| Other non-cash items | 158.95 Million | 360.58 Million | -294.95 Million | 2.65 Billion | 2.14 Billion | -1.33 Billion |
| Investing Cash Flow | -359.31 Million | -169.12 Million | -360.73 Million | 694.64 Million | 795.91 Million | -133.77 Million |
| Investments in PPE | -254.14 Million | -175.03 Million | -261.23 Million | -145.91 Million | -753.06 Million | -183.31 Million |
| Acquisitions | -803.92 Million | 910.65 Thousand | 575.67 Thousand | -89.61 Million | -39.03 Million | -32.31 Million |
| Investment purchases | -913.34 Million | -696 Million | -863.07 Million | -395.67 Million | -4.65 Billion | -1.44 Billion |
| Sales/Maturities of investments | 1.61 Billion | 701 Million | 763 Million | 1.32 Billion | 6.24 Billion | 1.42 Billion |
| Other Investing Activities | 1.71 Million | 61 Million | -48.56 Million | 1.02 Billion | 1.93 Billion | 100.31 Million |
| Financing Cash Flow | 3.5 Million | -77.03 Million | -484.05 Million | -782.24 Million | -1.78 Billion | -324.46 Million |
| Debt repayment | -324.12 Million | -52.9 Million | -279.99 Million | -1.44 Million | -683.1 Million | -641.6 Million |
| Dividends payments | - | -95.35 Million | -4.2 Million | -797.5 Million | -797.5 Million | -5.17 Million |
| Common Stock Repurchased | 194.98 Million | -194.98 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -515.6 Million | 284.49 Million | -204.06 Million | 297.41 Million | -24.12 Million | 322.31 Million |
| Accounts receivables | - | -125.25 Million | - | 182.4 Million | 182.4 Million | -319.05 Million |
| Accounts payables | - | - | - | - | -578.41 Million | 28.78 Million |
| Inventory | - | -74.48 Million | - | -53.1 Million | -53.1 Million | -48.07 Million |
| Other working capital | - | -2.21 Million | - | 35.17 Million | 35.17 Million | -28.78 Million |
| Cash at beginning of period | 3.91 Billion | 3.75 Billion | 4.7 Billion | 3.86 Billion | 4.52 Billion | 4.23 Billion |
| Cash at end of period | 3.91 Billion | 3.91 Billion | 3.75 Billion | 4.7 Billion | 4.7 Billion | 3.84 Billion |
| Capital Expenditure | -254.14 Million | -175.03 Million | -261.23 Million | -145.91 Million | -753.06 Million | -183.31 Million |
| Effect of forex changes on cash | - | 5.58 Million | 2.5 Million | -8.26 Million | -1.65 Million | 870.59 Thousand |
| Net cash flow / Change in cash | 591.41 Thousand | 165.76 Million | -954.22 Million | 842.51 Million | 179.25 Million | -393.16 Million |
| Free Cash Flow | 73.62 Million | 237 Million | -373.76 Million | 784.02 Million | 544.62 Million | -119.12 Million |
ARMK
NNDNF
6596
3096
TAOIF
MDTC